Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership56,716 shares
Latest Disclosed Value $ 3,196,514
Engineers Gate Manager LP reports 143.83% increase in ownership of HAE / Haemonetics Corporation

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 56,716 shares of Haemonetics Corporation (US:HAE) valued at $3,196,514 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 23,260 shares of Haemonetics Corporation. This represents a change in shares of 143.83% during the quarter. The current value of the position is $3,736,450 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 56,716 33,456 143.83 3,197 71.46 0.0400
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 23,260 -81,579 -77.81 1,864 -63.52 0.0221
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 104,839 94,076 874.07 5,110 536.24 0.0585
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 10,763 -14,890 -58.04 803 -50.74 0.0100
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 25,653 22,953 850.11 1,630 676.19 0.0275
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 2,700 -26,154 -90.64 211 -90.94 0.0037
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 28,854 -13,304 -31.56 2,319 -33.50 0.0453
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 42,158 -47,242 -52.84 3,488 -54.30 0.0787
2024-05-15 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 89,400 81,019 966.70 7,630 965.64 0.2009
2024-02-14 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 8,381 1,389 19.87 717 14.38 0.0205
2023-11-14 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 6,992 723 11.53 626 17.45 0.0232
2023-08-14 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 6,269 714 12.85 534 16.12 0.0202
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 5,555 -7,829 -58.50 460 -56.37 0.0192
2023-02-14 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 13,384 13,384 1,053 0.0632
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 0 -41,522 -100.00 0 -100.00
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 41,522 41,522 2,202 0.0990
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -27,709 -100.00 0 -100.00
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 27,709 13,350 92.97 1,847 15.87 0.1188
2021-05-17 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 14,359 11,364 379.43 1,594 347.75 0.0790
2021-02-16 2020-12-31 13F HAEMONETICS COM 405024100 2,995 -3,896 -56.54 356 -40.77 0.0154
2020-11-16 2020-09-30 13F HAEMONETICS COM 405024100 6,891 -14,551 -67.86 601 -68.70 0.0282
2020-08-17 2020-06-30 13F HAEMONETICS COM 405024100 21,442 14,823 223.95 1,920 190.91 0.0977
2020-05-15 2020-03-31 13F HAEMONETICS COM 405024100 6,619 -21,265 -76.26 660 -79.40 0.0475
2020-02-14 2019-12-31 13F HAEMONETICS COM 405024100 27,884 25,232 951.43 3,204 856.42 0.1409
2019-11-14 2019-09-30 13F HAEMONETICS COM 405024100 2,652 2,652 335 0.0170
2019-08-14 2019-06-30 13F HAEMONETICS COM 405024100 0 -4,800 -100.00 0 -100.00
2019-05-15 2019-03-31 13F HAEMONETICS COM 405024100 4,800 4,800 420 0.0254
2018-05-07 2018-03-31 13F HAEMONETICS COM 405024100 0 -21,528 -100.00 0 -100.00
2018-02-01 2017-12-31 13F HAEMONETICS COM 405024100 21,528 21,528 1,250 0.0858
2015-11-16 2015-09-30 13F HAEMONETICS COM 405024100 0 -14,683 -100.00 0 -100.00
2015-08-14 2015-06-30 13F HAEMONETICS COM 405024100 14,683 14,683 607 0.0594
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.